Nonhematopoietic β-Arrestin-1 Inhibits Inflammation in a Murine Model of Polymicrobial Sepsis  by Sharma, Deepika et al.
The American Journal of Pathology, Vol. 184, No. 8, August 2014IMMUNOPATHOLOGY AND INFECTIOUS DISEASES
Nonhematopoietic b-Arrestin-1 Inhibits Inﬂammation in
a Murine Model of Polymicrobial Sepsis
Deepika Sharma,* Nandakumar Packiriswamy,y Ankit Malik,* Peter C. Lucas,z and Narayanan Parameswaranx
ajp.amjpathol.orgFrom the Graduate Programs in Microbiology and Molecular Genetics* and Comparative Medicine and Integrative Biologyy and the Department of
Physiology,x Michigan State University, East Lansing, Michigan; and the Department of Pathology,z University of Pittsburgh, Pittsburgh, PennsylvaniaAccepted for publicationC
P
hMay 7, 2014.
Address correspondence to
Narayanan Parameswaran,
Ph.D., 567 Wilson Rd., Room
3165, Department of Physi-
ology, Michigan State Univer-
sity, East Lansing,
MI 48824. E-mail: paramesw@
msu.edu.opyright ª 2014 American Society for Inve
ublished by Elsevier Inc. All rights reserved
ttp://dx.doi.org/10.1016/j.ajpath.2014.05.002b-Arrestin-1 (bArr1), a scaffolding protein critical in G-protein coupled receptor desensitization has more
recently been found to be important in the pathogenesis of various inﬂammatory diseases. We sought to
understand the role of bArr1 in sepsis pathogenesis using a mouse model of polymicrobial sepsis.
Although in previous studies we established that bArr1 deﬁciency protects mice from endotoxemia, here
we demonstrate that the absence of bArr1 remarkably renders mice more susceptible to mortality in
polymicrobial sepsis. In accordance with the mortality pattern, early production of inﬂammatory medi-
ators was markedly enhanced in bArr1 knockout mice systemically and locally in various organs. In
addition, enhanced inﬂammation in the heart was associated with increased NFkB activation. Compared
to these effects, immune cell inﬁltration, thymic apoptosis, and immune suppression during poly-
microbial sepsis were unaffected by a deﬁciency of bArr1. Additionally, enhanced inﬂammation and
consequent higher mortality were not observed in heterozygous mice, suggesting that one allele of bArr1
was sufﬁcient for this protective negative regulatory role. We further demonstrate that, unexpectedly,
bArr1 in nonhematopoietic cells is critical and sufﬁcient for inhibiting sepsis-induced inﬂammation,
whereas hematopoietic bArr1 is likely redundant. Taken together, our results reveal a novel and previously
unrecognized negative regulatory role of the nonhematopoietic bArr1 in sepsis-induced inﬂammation.
(Am J Pathol 2014, 184: 2297e2309; http://dx.doi.org/10.1016/j.ajpath.2014.05.002)Supported by NIH grants HL095637, AR055726, and AR056680 (N.P.),
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Disclosures: None declared.Sepsis is a serious medical condition that to date incurs high
mortality (approximately 30% to 50%) despite high expendi-
ture in terms of patient care. Early detection, antibiotics, and
life support tomaintain organ homeostasis remain the only line
of defense with no speciﬁc treatments available. Therefore,
understanding the mechanistic basis of sepsis progression is
critical in identifying potential therapeutic targets for future
drug development. Among the various pathophysiological
events that occur through sepsis progression, inﬂammation
remains a double-edged sword for the host, with dysregulated
proinﬂammatory phase causing tissue destruction1 and a pro-
longed immunosuppressed phase causing excessive microbial
burden. A balanced inﬂammatory response protects patients
from sepsis-induced morbidity and mortality. Therefore,
elucidating mechanisms regulating inﬂammation is critical to
our understanding of sepsis pathogenesis.
b-Arrestins (1 and 2), initially identiﬁed as being involved
in G-protein coupled receptor (GPCR) desensitization are now
known to have diverse array of roles in GPCR-dependentstigative Pathology.
.and -independent signaling.2 This gives arrestins an opportune
foothold in various physiological functions and places them as
important regulators of homeostasis. Arrestins’ role in medi-
ating inﬂammation stems from their ability to modulate
chemotaxis,3 cytokine production, and signaling via nonca-
nonical regulators of inﬂammation, such as beta-adrenergic,4
angiotensin,5 lipid, and other receptors. Additionally, they
can act as scaffolding proteins for major signaling com-
plexes, including mitogen-activated protein kinase
(MAPK)6,7 and NFkB pathways.8,9 In vitro studies have
demonstrated a negative regulatory role for b-arrestin-1
(bArr1) in Toll-like receptor-4 (TLR-4) and tumor necrosis
factor receptor (TNFR) signaling.8,10,11 However, we
Sharma et aldemonstrated in previous studies that bArr1 is a critical
mediator of inﬂammation and mortality in the endotoxemia
model of sepsis.12 Consistent with that, other studies have
also shown that bArr1 mediates the pathogenesis of various
inﬂammatory diseases, such as rheumatoid arthritis,13 co-
litis,14 cancer,15 and multiple sclerosis.16,17
Despite the limitations of mouse models in replicating
human sepsis, cecal ligation and puncture (CLP)-induced
polymicrobial sepsis has been shown to encompass several
immunopathological features of human sepsis.18 Based on a
previously reported role of bArr1 in endotoxemia and other
inﬂammatory models, we hypothesized that bArr1-deﬁcient
mice will be protected from polymicrobial sepsis-induced
inﬂammation and mortality. Our studies, however, reveal
a previously unappreciated negative regulatory role of
bArr1 in polymicrobial sepsis and consequent mortality. We
further demonstrate in this study that bArr1 in the non-
hematopoietic compartment is required and sufﬁcient to
regulate polymicrobial sepsis-induced inﬂammation.
Materials and Methods
Animals
barr1 knockout (KO) mice on a C57BL/6 background (pro-
vided by Dr. Robert Lefkowitz, Duke University) have been
described earlier.12 Wild-type (WT) C57BL/6 mice were
purchased from the National Cancer Institute, and all mice
were bred or housed at Michigan State University (East
Lansing, MI) in rooms maintained at 22C to 24C with 50%
humidity and a 12-hour lightedark cycle. Mouse chow and
waterwere providedad libitum to all animals.All experiments
were performed with age- and sex-matched mice between 8
and 12 weeks of age. Animal procedures were approved by
Michigan State University Institutional Animal Care and Use
Committee and conformed to NIH guidelines.19
CLP Surgery
Animals were subjected to CLP as described earlier.20 Brieﬂy,
mice were anesthetized using i.p. injection of 5 mg/kg xyla-
zine and 80 mg/kg ketamine. The cecum was exteriorized,
ligated, and punctured either once [single puncture (SP)] with
a 16-guage needle (16G-SP) or twice [double puncture (DP)]
with a 20-guage needle (20G-DP). The cecum was then
reinserted and the peritoneal cavity sutured with 5.0 silk
(Syneture; Covidian, Mansﬁeld, MA). Sham surgery wherein
the cecum was exteriorized, but neither ligated nor punctured,
was used as control. All animals were given a s.c. injection of
1 mL of saline (prewarmed to 37C) after the surgery. For
mortality studies, mice were observed for 7 days after surgery.
Generation of Chimeric Mice
Chimeric mice were generated using lethal irradiation and
bonemarrow reconstitution. Brieﬂy, mice were irradiated with2298a total dose of 11 gy (5.5 gy  2, 3 hours apart) and 12 hours
later injected with 5  106 bone marrow cells from a donor.
Immediately after irradiation and reconstitution, mice were put
on water with antibiotics (sulfamethoxazole and trimethoprim;
Hi-Tech Pharmacal, Amityville, NY) for 4 weeks, and mice
were used for experiments 8 weeks after reconstitution.
Sample Processing
At a predetermined time of harvesting, mice were euthanized
using carbon dioxide asphyxiation. Peritoneal ﬂuid, plasma,
and organs were harvested and processed as previously
stated.21 Brieﬂy, the peritoneal cavity was ﬂushed with R10
medium (RPMI 1640 with 10% fetal bovine serum, 100 U/
mL penicillin, 100 mg/mL streptomycin, and 55 mmol/L b-
mercaptoethanol), the cells collected and then processed for
ﬂuorescence-activated cell-sorting analysis. The ﬁrst perito-
neal wash was done in 4 mL of medium, and the supernatant
was saved for further analysis. The cavity was then lavaged
twice with 10 mL of medium, and cells from all washes were
collected and counted for further analysis. Blood was
centrifuged at 300 g for 5 minutes, and the supernatant was
stored at 80C for enzyme-linked immunosorbent assay
(ELISA). The organs were harvested, ﬂash frozen, and then
stored at 80C. Spleen was crushed, subjected to red blood
cell lysis, and then ﬁltered through 40-mm nylon mesh. For
further stimulations, cells were counted, resuspended in R10
at a concentration of 10 106 cells/mL, and then incubated at
37C for 18 hours with or without lipopolysaccharide (LPS;
100 ng/mL). For ﬂow cytometric analysis, 2 106 cells were
used and processed. Thymus was processed similar to the
splenocytes, and samples were prepared for cytometric
analysis. For bronchoalveolar lavage collection, the thoracic
cavity was opened, and the trachea was cannulated and then
secured with ligation. The bronchoalveolar space was lav-
aged three times using R10 medium, and the cells pooled
from the three washes for cytometric analysis.
Flow Cytometry
Peritoneal, bronchoalveolar-lavage, spleen, and thymus cells
collected from septicmicewere processed as described above.
They were then stained with an antibody cocktail made in
2.4G2 supernatant fcg-receptor blocking antibody to block
nonspeciﬁc binding, and then washed with staining buffer
(phosphate-buffered saline with sodium azide and bovine calf
serum). The antibodies against cell-surface markers CD11b,
F4/80, granulocyte-differentiation antigen (Gr-1), CD3,
CD19, CD4, and CD8 were obtained from eBiosciences (San
Diego, CA) and used as per the manufacturer’s instructions.
Cells were run on a BD LSR II ﬂow cytometer (BD Bio-
sciences, San Jose, CA), and data were analyzed using FlowJo
software version 10.0 (TreeStar, Ashland, OR). Neutrophils
were gated as CD3CD19CD11bþGr-1þ cells, macro-
phages as CD3CD19CD11bþF4/80þ cells, and T cells as
CD19CD3þ cells. T cells were further marked as CD4þ (Tajp.amjpathol.org - The American Journal of Pathology
b-Arrestin-1 Inhibits Inﬂammationhelper), CD8þ (cytotoxic), and CD4þCD8þ (double-positive)
T cells based on CD4 and CD8 expression.
Cytokine/Chemokine Measurements
Cytokines were measured from plasma, splenic culture su-
pernatant, and peritoneal ﬂuid using ELISA kits from
eBiosciences, as per the manufacturer’s protocol. To pool
the data from multiple bone-marrow transfer experiments,
the raw values were converted to fold change over the
average WT concentrations for each experiment.
Bacterial Counts
Bacterial load was determined in peritoneal ﬂuid and blood.
Brieﬂy, the sample was serially diluted and plated on Difco
Mueller Hinton agar plates (Becton, Dickinson and Com-
pany, Franklin Lakes, NJ). The plates were then incubated
at 37C for 24 hours, and the number of colony-forming
units (CFU) were counted and recorded.
Preparation of Polymicrobial Culture
Polymicrobial culture was obtained as described previ-
ously.21 Brieﬂy, cecal contents collected from WT mice
were inoculated in sterile medium (BD Bacto Brain Heart
Infusion; Becton, Dickinson and Company) and cultured at
37C with 220 rpm shaking for 18 hours. The contents were
then centrifuged at 432  g for 10 minutes; the bacterial
pellet was resuspended in 40% glycerol and then stored at
80C. For CFU measurements, 100 mL of the poly-
microbial culture was inoculated in 100 mL of medium and
grown for 14 hours, washed with phosphate-buffered saline,
and then plated on Mueller Hinton agar (Becton, Dickinson
and Company) plates using serial dilution. Once the CFU/
mL for the culture was determined, it was diluted to obtain
the required CFU count for the experiments.
Bacterial Killing Assay
Intracellular and total killing assays were performed using
thioglycollate-elicited neutrophils. To obtain neutrophils,
mice were injected with 1 mL of thioglycollate i.p., and 4
hours later, cells were collected using peritoneal lavage.
Escherichia coli (ATCC 25922; ATCC, Manassas, VA) was
cultured in tryptic soy broth overnight, and a secondary
culture was started from it for the assay. Four hours later, the
culture was spun at 5000 rpm for 15 minutes, washed twice
with sterile PBS, and the expected CFU count was calculated
based on the optical density value and previously determined
growth curve. It was then opsonized for 1 hour at 37C with
heat-inactivated serum (55C for 1 hour) with mild shaking
(100 rpm). Neutrophils and bacteria were mixed at a multi-
plicity of infection of 1:5 and incubated at 37C with mild
shaking (100 rpm). For the total killing assay, a bacteria-
alone control was set up as well, and at indicated times,
both control and experimental groups were serially dilutedThe American Journal of Pathology - ajp.amjpathol.organd plated to obtain CFU counts. For the intracellular killing
assay, 10 mg/mL gentamicin was added to kill extracellular
bacteria 20 minutes later. Following gentamycin treatment
(20 minutes), the cells were washed in phosphate-buffered
saline to remove gentamicin and then incubated for the
indicated time periods at optimum conditions. At the end of
each time period, the cells were lysed in 0.1% Triton X-100,
serially diluted, and then plated to obtain CFU counts.
Quantitative RT-PCR
To determine the relative levels of a speciﬁc RNA transcript,
RNA was isolated from snap-frozen tissue using an RNeasy
mini kit (Qiagen, Valencia, CA) using the manufacturers’
protocol. Reverse transcription was performed with 1 mg of
RNA using a cDNA synthesis kit (Promega, Madison, WI).
Quantitative RT-PCR was performed with an ABI 7500 Fast
Real-Time PCR System (Applied Biosystems; Life Tech-
nologies, Foster City, CA), and all genes were normalized to
HPRT as previously described.21 Primer sequences are pro-
vided in Table 1. Data were normalized to WT for all genes.
Western Blotting
Snap-frozen heart tissue was homogenized in lysis buffer [20
mmol/L Tris-HCl (pH 7.4), 1 mmol/L EDTA, 150 mmol/L
NaCl] containing 1% Triton X-100 and protease and phos-
phatase inhibitors. Homogenized tissuewas spun at 15000 g
for 10 minutes at 4C. Protein concentration of the supernatant
was determined using the Bradford method. Western blots
were performed as previously described.21 Brieﬂy, equivalent
concentrations of protein samples were run on polyacrylamide
gels and then transferred to nitrocellulose membranes. Primary
antibodies used were phospho-extracellular-signal-regulated
kinase (p-ERK) (9101L; Cell Signaling Technology, Dan-
vers, MA), ERK2 (Sc-1647; Santa Cruz Biotechnology, Santa
Cruz, CA), phosphorylated inhibitor of NF-kB-alpha (pIkBa)
(9246S; Cell Signaling Technology), and IkBa (9242S; Cell
Signaling Technology), and secondary (anti-rabbit or anti-
mouse) antibodies were bought from Invitrogen (Life Tech-
nologies, Carlsbad, CA) or LI-COR (Lincoln, NE). Blots were
probed with the primary antibody followed by IR-dye/
horseradish peroxidase-conjugated secondary antibody and
then scanned. Bands were quantiﬁed using a LI-COROdyssey
scanner or ImageJ software version 1.46r (NIH, Bethesda,
MD). For data analysis, pERK1/2 was normalized to ERK2,
and pIkBa to IkBa, as loading controls.
Caspase Activity
Caspase 3 activity was assessed in thymocytes using the
ﬂuorescence assay described earlier.22 Brieﬂy, thymocytes
were lysed in CHAPS buffer (50 mmol/L HEPES, 0.1%
CHAPS, 1 mmol/L dithiothreitol, 0.1 mmol/L EDTA, 1
mmol/L phenylmethylsulfonyl ﬂuoride, and 10 mg/mL leu-
peptin). The cell lysate was quantiﬁed, and 10 mg protein2299
Table 1 Primer Sequences Used in qPCR Analysis
Primer/gene name Forward primer Reverse primer
TNFA 50-TCTCATCAGTTCTATGGCCC-30 50-GGGAGTAGACAAGCTACAAC-30
IL6 50-ACAAGTCGGAGGCTTAATTACACAT-30 50-TTGCCATTGCACAACTCTTTTC-30
NFKBIA 50-TGGCCAGTGTAGCAGTCTTG-30 50-GACACGTGTGGCCATTGTAG-30
NOS2 50-TCTTTGACGCTCGGAACTGTAGCA-30 50-ACCTGATGTTGCCATTGTTGGTGG-30
NOS3 50-CTGCTGCCCGAGAATATCTTC-30 50-CTGGTACTGCAGTCCCTCCT-30
ICAM 50-GGCACCCAGCAGAAGTTGTT-30 50-GCCTCCCAGCTCCAGGTATAT-30
VCAM 50-GGAGAGACAAAGCAGAAGTGGAA-30 50-ACAACCGAATCCCCAACTTG-30
SERPINE1 50-GGCACAGTGGCGTCTTCCT-30 50-TGCCGAACCACAAAGAGAAAG-30
F3 coagulation factor III 50-CATGGAGACGGAGACCAACT-30 50-CCATCTTGTTCAAACTGCTGA-30
PROCR 50-AGCGCAAGGAGAACGTGT-30 50-GGGTTCAGAGCCCTCCTC-30
qPCR, quantitative PCR.
Sharma et alwas incubated with a ﬂuorescent substrate (Ac-DEVD-AFC;
Enzo Life Sciences, Farmingdale, NY) in assay buffer [100
mmol/LHEPES, 10% sucrose, 0.1%CHAPS, and 10mmol/L
EDTA (pH 7.4)]. Fluorescence of the cleaved product was
measured (excitation at 400 nm and emission at 505 nm)
using a Tecan SpectraFluor Plus ﬂuorescence plate reader
(M1000 inﬁnite, Tecan, Switzerland). Data were analyzed
and presented as picograms of cleaved AFC ﬂuorophore
per milligram protein per minute, calculated using standard
curve of free AFC.
Phagocytosis and ROS Potential
Cells harvested from septic mice 12 hours after surgery were
used as the source of neutrophils for phagocytic potential andFigure 1 Role of b-arrestin-1 (bArr1) in sepsis-induced mortality and inﬂamma
zygous (b-Arr1þ/) mice were subjected to 16-guage needle single-puncture surge
genotypeswere subjected to cecal ligation andpuncture as indicated inA, andplasma
after surgery. nZ 10 to 12mice for each genotype (A); nZ 8 to 14, with data pooled
denote SEM. **P < 0.01 compared to WT by log-rank (Mantel Cox) test (A); *P < 0.
2300reactive oxygen species (ROS) generation. Brieﬂy, the peri-
toneal cavity was lavaged with R2 media (RPMI 1640 with
2% fetal bovine serum), and cells counted for the assay. For
phagocytosis, pHrodo E. coli BioParticle conjugate (Invi-
trogen; Life Technologies) was used as described in the
manufacturer’s manual. Cells (1  105) were incubated with
bioparticles for 30 minutes at either 37C (experimental) or
4C (control), and the reaction stopped by washing with cold
ﬂuorescence-activated cell-sorting wash buffer. For ROS
detection, 1 105 cells were preloaded with 5 mmol/L DHR-
123 dye (Invitrogen; Life Technologies) and stimulated with
phorbol myristate acetate (1 ng/mL). The cells were stained
with Gr-1 antibodies to detect neutrophils and the increase in
mean ﬂuorescence intensity over control, recorded as
phagocytic potential and ROS generation, respectively.tion. A: Wild-type (WT), barr1 knockout (KO) (b-Arr1/), and bArr1 hetero-
ry and observed for mortality over 7 days. B and C: Mice from the different
cytokine concentrations in septicmice determined at the indicated timepoints
from at least two independent experiments (B and C). Error bars on the ﬁgure
05, **P < 0.01, and ***P < 0.001 compared to WT using t-test (B and C).
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Figure 2 Role of b-arrestin-1 (bArr1) in cellular inﬁltration and bacterial
killing. Wild-type (WT; white bars), bArr1 knockout (KO; b-Arr1/; black
bars), and bArr1 heterozygous (b-Arr1þ/; gray bars) mice underwent sham
or cecal ligation and puncture surgeries and were euthanized at the deﬁned
time points. A: Neutrophil and macrophage inﬁltration in the peritoneal
cavity of shammice at 24 hours and septic mice at indicated time points after
surgery were determined using ﬂow cytometry. B: Bacterial load was rep-
resented as colony-forming units (CFU)/mL in the blood of septic mice at the
indicated time points and grades of sepsis. C: Bacterial killing capacity of
thioglycollate-elicited neutrophils from WT and KO mice was depicted as
surviving bacteria (CFU) recovered from the extracellular medium at the
indicated time points for total bacterial killing, and from cellular lysate at
various time points after 20minutes uptake for the intracellular killing assay.
Data for septic mice were pooled from three independent experiments. nZ 9
to 14 for septic mice and n Z 3 for sham (B); n Z 3 to 5 (C). Error bars
denote SEM. *P < 0.05 using Student’s t-test. 16G-SP, 16-guage needle
single puncture; 20G-DP, 20-guage needle double puncture.
b-Arrestin-1 Inhibits InﬂammationHistopathology
Liver, kidney, spleen, and lung tissues were collected from
mice subjected to CLP, and ﬁxed in 10% formalin overnight.
The tissues were then embedded in parafﬁn, sectioned, and
stained with hematoxylin and eosin. The hallmarks of injury
and inﬂammation (inﬁltration) were assessed by a board-
certiﬁed pathologist (P.C.L) in a blinded manner.
Statistical Analysis
All experimental data in the ﬁgures are expressed as
means SEM and analyzed using GraphPad Prism Software
version 5 (La Jolla, CA). Each n represents an individual
mouse. The Student’s t-test (for comparing groups with equal
variances) or Mann-Whitney U-test (for comparing groups
with unequal variances) was used to compare two experi-
mental groups. Differences in the survival were determined
using the log-rank test. P < 0.05 was considered statistically
signiﬁcant.
Results
bArr1 Inhibits Sepsis-Induced Mortality and
Inﬂammation
To assess the importance of bArr1 in modulating progres-
sion of sepsis, we subjected WT and bArr1 KO mice to CLP
surgery (16G-SP) and followed their survival over the
course of 7 days. We also included bArr1 heterozygous
(HET) mice to assess the gene dosage effect of bArr1 in
sepsis-induced mortality. In contrast to the role of bArr1 in
endotoxemia-induced mortality, we observed that all of the
KO mice succumbed to sepsis within 3 days of surgery,
whereas only approximately 45% of the WT mice died
(P Z 0.0032) (Figure 1A). Interestingly, HET mice had a
mortality rate similar to WT mice, suggesting that one allele
of bArr1 is sufﬁcient to inhibit sepsis-induced mortality
(Figure 1A). Because all of the KO mice died within 3 days
of surgery, we hypothesized that the deaths likely were
consequent to an early dysregulated inﬂammatory
response.23e25 Given that plasma cytokine levels, especially
IL-6, at an early time point are predictive of mortality in this
model, we assessed IL-6 production in response to the septic
insult. Associated with accelerated mortality, plasma IL-6
levels were signiﬁcantly elevated in septic KO mice at
both 6 and 12 hours after sepsis compared to the WT
(Figure 1B). At 24 hours after sepsis, IL-6 levels decreased
signiﬁcantly and were similar between the WT and KO
mice. Similarly, tumor necrosis factor a (TNFa), IL-12p40,
and IL-10 levels were also signiﬁcantly elevated in septic
KO mice as compared to the WT 12 hours after CLP and
decreased to WT levels by 24 hours after sepsis (Figure 1C).
This exaggerated early cytokine response was not observed
in septic HET mice, consistent with their mortality being
similar to that of WT.The American Journal of Pathology - ajp.amjpathol.orgRegulation of Bacterial Clearance and Cellular
Inﬁltration by bArr1
Cellular inﬁltration into the site of injury and bacterial
clearance are critical factors impacting both inﬂammation
and mortality26,27 and could potentially contribute to a
hyperinﬂammatory phenotype in septic KO mice. Exami-
nation of cellular inﬁltrate into the peritoneal cavity revealed
marked neutrophil inﬁltration in response to septic insult,
but no signiﬁcant difference between the three genotypes at
both 12 and 24 hours after surgery (Figure 2A). In this grade
of sepsis, peritonitis did not induce an increase in macro-
phage numbers at the site of infection even by 24 hours,
which was nonetheless similar between the genotypes
(Figure 2A). This suggests that cellular inﬁltration to the site
of infection is likely not regulated by bArr1.
Interestingly, bacterial load in blood, too, was similar be-
tween WT and KO septic animals subjected to 16G-SP2301
Sharma et al(Figure 2B). Bacterial load, however, was higher in the septic
KO mice subjected to 20G-DP, suggesting that the role of
bArr1 in bacterial clearance in vivo is perhaps dependent on
the severity of sepsis induction (Figure 2B).28 HET mice,
however, had bacterial loads similar to septicWTmice in both
CLP models. To probe the potential role of bArr1 in bacteri-
cidal activity independent of the confounding effect of ensuing
inﬂammation, we examined the ability of thioglycollate-
elicited neutrophils from WT and KO mice to kill bacteria
in vitro. As shown, we did not observe any role for bArr1 in
the intracellular or total in vitro bacterial killing assays
(Figure 2C). It is possible that even though bArr1 KO neu-
trophils do not seem to have any apparent defect in their ability
to perform efﬁcient bacterial killing, bArr1might differentially
regulate the effect of inﬂammation on bactericidal activity. It
must be noted that in both models (16G-SP and 20G-DP),
early levels of plasma IL-6 and IL-10 were signiﬁcantly higher
in septic KO mice as compared to the WT (Figure 1 and
Supplemental Figure S1A), even though bacterial clearance
was differentially affected (Figure 2B). Additionally, perito-
neal inﬁltration of neutrophils and macrophages was similar
between the septic WT and bArr1 KO animals in both grades
of sepsis (Figure 2 and Supplemental Figure S1B). Thus, the
exacerbated systemic cytokine levels in the septic KOmice areFigure 3 Role of b-arrestin-1 (bArr1) in sepsis-induced organ inﬂammation.
bArr1 heterozygous (b-Arr1þ/; gray bars) mice were subjected to 16G-single punc
for analysis. IL-6 levels (pg/mg) in organ lysates (determined by ELISA) from sept
inﬂammatory mediators in heart (B), liver (C), and lung tissue (D) from septic mi
ﬂow cytometry isolated from bronchoalveolar lavage of septic mice 24 hours after
WT. Protein and RNA data are represented as fold WT and are pooled from at leas
denote SEM. *P < 0.05, **P < 0.01, and ***P < 0.001 using Student’s t-test.
2302likely independent of systemic bacterial load or cellular inﬁl-
tration to the site of infection.
bArr1 Inhibits Tissue Inﬂammation
Inﬂammatory mediators induced by septic insult are capable
of inﬂicting host tissue damage due to excessive/injudicious
production.1,29 Even though histopathological lesions of
tissue damage are not evident in early sepsis in major tissues
including lung and liver,30,31 mortality is consequent to
multiple organ dysfunction in sepsis. Given the mortality
pattern of septic KO mice, we hypothesized that expression
of inﬂammatory mediators (associated with organ dysfunc-
tion) would be higher in septic KO mice. Similar to plasma,
IL-6 levels were signiﬁcantly higher in heart, liver, and lung
of septic KO as compared to WT mice 12 hours after CLP
(Figure 3A). In addition to assessing IL-6 protein levels, we
also examined the mRNA expression of several inﬂamma-
tory mediators in various tissues as follows:
Heart
Cardiac mRNA expression of IL-6 and TNFa was signiﬁ-
cantly higher in the septic KO, as compared to septicWTmice
(Figure 3B). Associated with these two proinﬂammatoryA: Wild-type (WT; white bars), bArr1 knockout (b-Arr1/; black bars), and
ture surgery, and the indicated organs were collected at deﬁned time points
ic mice 12 hours after surgery. BeD: Quantitative real-time PCR analysis of
ce 12 hours after surgery. E: Total number of neutrophils as determined by
surgery. mRNA expression was normalized to HPRT before converting to fold
t two independent experiments. n Z 8 to 17 for each genotype. Error bars
ajp.amjpathol.org - The American Journal of Pathology
Figure 4 b-arrestin-1 (bArr1) inhibits cardiac NFkB signaling. Wild-type
(WT; white bars) and bArr1 knockout (KO) (b-Arr1/; black bars) mice were
subjected to 16-guage needle single-puncture surgery, and heart tissue was
collected 12 hours after surgery. AeC: Representative blots (A) and quanti-
tative presentation of phosphorylation status of IkBa (B) and ERK1/2 (C) in
heart lysates from septic mice. B and C: Note that pIkBa was normalized to
IkBa, and pERK1/2 to ERK2, for loading control.D: Real-time quantitative RT-
PCR for NFKBIA (IkBa) mRNA expression in heart tissue from septicmice. Data
are pooled from two independent experiments.nZ 8 to 10 for each genotype.
Error bars denote SEM. *P < 0.05, **P < 0.01 using Student’s t-test.
b-Arrestin-1 Inhibits Inﬂammationcytokines, expression of nitric oxide synthase 2/3 (NOS2/
NOS3) was also markedly enhanced in KO hearts, suggesting
increased nitric oxide (NO) production from an inducible NOS
allele and possible loss of protective effects of endothelial
NOS.32 Together in the presence of higher levels of cytokines
such as IL-6, this could lead to exacerbated cardiac dysfunc-
tion in the KO mice.
Liver
In contrast to cardiac tissue, liver mRNA expression of IL-6
and TNFa was similar in septic mice of both genotypes (data
not shown), even though the IL-6 protein level was higher in
tissue from septic KO mice (Figure 3A). However, mRNA
expression of coagulation factors, coagulation factor III [F3
(tissue factor)] and protein C receptor (PROCR), endothelial
PROCR (EPCR), as well as NOS2/NOS3, were markedly
elevated in septic KO livers compared to the WT mice
(Figure 3C). Increased PROCR expression in the endotox-
emia model has been shown to occur via proteinase-activated
receptor 1 (PAR-1)edependent thrombin signaling, linking
it to increased thrombin production and impaired anti-
inﬂammatory and anticoagulation pathways.33 This procoa-
gulant and increased NO production is potentially
detrimental for liver tissue and could lead to excessive liver
dysfunction in the KO mice.34
Lungs
Similar to the cardiac tissue, lungs from septic KO mice also
exhibited signiﬁcantly higher mRNA expression of IL-6 and
TNFa, as compared to the septic WT mice (Figure 3D). In
addition, we also observed enhanced mRNA expression of
procoagulant factor serpin peptidase inhibitor, clade E,
member 1 (SERPINE1) (plasminogen activator inhibitor
(PAI) as well as that of the adhesion molecules intercellular
adhesion molecule (ICAM) and vascular cell-adhesion
molecule 1 (VCAM) in the septic KO compared to the WT
mice lungs (Figure 3D). Consistent with enhanced adhesion
molecule expression, the number of bronchoalveolar lavage
neutrophils was signiﬁcantly higher in KO compared to the
WT septic mice, at a later time point (24 hours) (Figure 3E).
Because lung neutrophil sequestration has been shown to
correlate with lung tissue damage in a sepsis model,35
enhanced inﬂammation in the septic KO lung could lead to
higher pulmonary dysfunction in septic KO animals.
Overall, the tissues examined showed an exacerbated
inﬂammatory gene expression proﬁle in KO mice compared
to the WT mice, which together with the higher mortality
suggest a greater extent of organ dysfunction in response to
polymicrobial sepsis. In contrast to the KO mice, and as
expected, tissues for septic HET mice had similar levels of
inﬂammatory mediators to that of septic WT mice (Figure 3,
AeE), consistent with comparable mortality between WT
and HET mice. Histological examination of major organs
(including lung, liver, kidney, and heart) from septic ani-
mals, however, displayed minimal differences between WT
and KO animals at both 24 (data not shown) and 48 hoursThe American Journal of Pathology - ajp.amjpathol.orgafter surgery (Supplemental Figure S2). Histopathological
assessment of organ injury in the CLP model has been a bit
controversial, and recent studies have demonstrated that
there are minimal histopathological differences in major
organs of septic mice predicted to live versus those pre-
dicted to die, even up to 48 hours after surgery.29,30
bArr1 Inhibits Cardiac IkBa Phosphorylation
The enhanced proinﬂammatory signature observed in tis-
sues from bArr1 KO mice suggested enhanced activation of
signaling pathways. bArr1 has been shown to be an
important regulator of NFkB8 and MAPK pathways
involved in production of inﬂammatory mediators.7,9,36,37
To ascertain whether bArr1 modulates signaling via any
of these pathways and to correlate the gene expression to
signaling, we determined activation status of these pathways
in the heart lysates from septic mice. Consistent with the
expected pattern, pIkBa levels (Figure 4, A and B) were
enhanced in the heart lysate from septic KO mice as
compared to WT mice. This was speciﬁc for IkBa because
the phosphorylation status of other pathways, including
ERK (Figure 4, A and C), was comparable in heart lysates
from septic WT and KO mice. Note that phosphorylation of
other NFkB and MAPK molecules, including P65, P105,2303
Table 2 T-Cell Distribution in Lymphoid Organs of Sham Mice
Organ WT bArr1/ bArr1þ/
Thymus
CD4þCD8þ 5.0  0.6  107 5.7  1.6  107 3.8  1.2  107
Spleen
CD4þ 6.6  0.3  106 6.3  0.6  106 7.3  0.9  106
CD8þ 4.8  0.2  106 4.5  0.5  106 5.3  0.8  106
n Z 4 to 6 for each genotype.
WT, wild type.
Figure 5 Role of b-arrestin-1 (bArr1) in sepsis-induced lymphocyte
apoptosis. Wild-type (WT; white bars), bArr1 knockout (b-Arr1/; black
bars), and bArr1 heterozygous (b-Arr1þ/; dark gray bars) mice were sub-
jected to 16-guage needle single-puncture surgery, and thymus and spleen
were collected 24 hours after surgery for the indicated parameters/analysis.A
and B: CD4þCD8þ T cells in thymus as determined by ﬂow cytometry (A) and
caspase-3 activity in thymic lysates of septic mice as compared to WT/sham
(light gray bars) (B). C and D: CD4þ and CD8þ T cells in spleen as determined
by ﬂow cytometry (C) and caspase-3 activity in splenic lysates from septic
mice as compared to WT/sham (D). Data are pooled from at least three in-
dependent experiments for septic mice. nZ 4 to 6 for sham and nZ 10 to 19
for septic mice for each genotype (AeC); nZ 4 to 5 (D). Error bars denote
SEM. *P < 0.05, **P < 0.01, and ***P < 0.001 using Student’s t-test.
Sharma et alc-Jun N-terminal kinase (JNK), and p38, in septic mice of
either genotype was either undetectable or very low (data
not shown). However, because this was a single time point
analysis, differential activation of these signaling players
during the course of the infection cannot be denied. None-
theless, because there was enhanced activation of IkBa
phosphorylation in the KO mice, we examined the mRNA
levels of NFKBIA (IkBa), whose promoter is activated by
NFkB.38 Consistent with enhanced IkBa phosphorylation in
the KO hearts, mRNA expression of IkBa was signiﬁcantly
enhanced in the KO compared to the WT hearts
(Figure 4D). Together, these results suggest a negative
regulatory role for bArr1 in NFkB activation in cardiac
tissue in response to a septic insult and potentially links
increased inﬂammatory mediator production to higher
NFkB activation in the bArr1 KO mice.
Thymus Apoptosis and Immune-Suppression Are
Unaffected by Loss of bArr1
Lymphocyte apoptosis and innate immune suppression have
drastic consequences in progression of sepsis39 and have
been correlated with a dysregulated inﬂammatory cascade
associated with mortality.40,41 Given that sepsis progression
was worse in the KO mice, we wanted to examine whether
the detrimental effects of lymphocyte apoptosis and immune
suppression played any role in the ﬁnal outcome. To eval-
uate the extent of apoptosis induced in response to sepsis,
lymphocyte cellular proﬁle was evaluated in thymus and
spleens of sham and septic mice. Note that the cellular
proﬁle in thymus and spleen of sham mice was unaffected
by the zygosity of bArr1 (Table 2). Sepsis induced a drastic
reduction in number (and proportion) of thymic CD4þCD8þ
(double positive) T cells, that was comparable between WT,
KO, and HET septic mice (Figure 5A). Additionally,
caspase-3 activity that was signiﬁcantly induced in response
to sepsis was similar between thymic tissues from septic
mice of all genotypes (Figure 5B). Although septic WT
spleen did not exhibit signiﬁcant loss in CD4þ
(PZ 0.0563) or CD8þ T cells compared to sham mice, the
numbers of both T cell types were signiﬁcantly lower in
septic KO mice as compared to septic WT (Figure 5C).
Splenic CD4þ T cells were also lower in septic HET mice,
similar to that of the KO. Additionally, caspase-3 activity in
spleen, even though slightly induced at this time point, was2304similar between the three genotypes in response to sepsis
(Figure 5D). The discrepancy in the spleen and thymus of
KO septic mice with regard to the effect on T cells may be
due to lower expression of bArr1 in thymus as compared to
the spleen.16 Additionally, CD4þ T cells have a greater
amount of nuclear bArr1, hence might be affected to a
greater extent by its zygosity as compared to CD8þ T cells.
To assess immune suppression, peritoneal and splenic cells
from septic mice were stimulated with LPS as secondary
stimuli, and the extent of cytokine production determined.
Both cell populations responded to further stimuli even
though splenic response [IL-6, P < 0.01; TNFa, P < 0.005;
interferon-g (IFN-g), P < 0.01] was more pronounced as
compared to peritoneal cells (IL-6, P Z 0.07; TNFa,
P < 0.05; IFN-g, P < 0.05, using a one-tailed t-test)
(Figure 6, A and B). In the absence of secondary stimuli
(control), KO splenocytes exhibited signiﬁcantly higher
TNFa and IFN-g production (Figure 6A), whereas peritoneal
cells produced higher IFN-g (Figure 6B) (PZ 0.05). Given
that the cells had undergone exposure to LPS in vivo to
assess immune suppression in response to secondary LPSajp.amjpathol.org - The American Journal of Pathology
Figure 6 Role of b-arrestin-1 (bArr1) in sepsis-induced immune-suppression. Wild-type (WT; white bars), bArr1 knockout (b-Arr1/; black bars), and
bArr1 heterozygous (b-Arr1þ/; gray bars) mice were subjected to 16-guage needle single-puncture surgery, and spleen and peritoneal cells were collected 24
hours after surgery and processed. Cells were then plated and left untreated (control) or stimulated for 18 hours with 100 ng/mL lipopolysaccharide (LPS).
A and B: Cytokine levels in the supernatants in splenocytes (A) and peritoneal cells (B) in control and LPS stimuli as determined by ELISA. Data are presented
as fold change over WT control. C: Phagocytic potential and reactive oxygen species (ROS) generation in peritoneal cells from septic mice presented as mean
ﬂuorescence intensity (MFI) increase over controls. Data were pooled from three independent experiments. n Z 8 to 10. Error bars denote SEM. *P < 0.05,
**P < 0.01, and ***P < 0.001 using Student’s t-test (A and B).
b-Arrestin-1 Inhibits Inﬂammationstimulation, data were converted to fold change over control
for each individual animal. There was no statistically sig-
niﬁcant difference between the three genotypes in regard to
the ability of splenic or peritoneal cell populations to
respond to the secondary stimuli (Table 3). However, spleen
TNFa production was signiﬁcantly higher in the KO
compared to the WT, both without and with secondary
stimulation (Figure 6A). To further assess the role of bArr1
in innate cell dysfunction, we determined the phagocytic
potential and ROS generation capacity of peritoneal neu-
trophils from septic mice28 and found neither to be affected
by loss of bArr1 in response to a septic insult (Figure 6C).
Taken together, these results suggest that innate immune
suppression following septic insult was unaffected by the
loss of bArr1.The American Journal of Pathology - ajp.amjpathol.orgNonhematopoietic bArr1 Negatively Regulates
Inﬂammation Following Sepsis
Based on the mortality pattern, we predicted that exacerbated-
inﬂammation was the likely cause of poor outcome in KO
animals. In accordance, both systemic and tissue inﬂammation
from septic animals were signiﬁcantly higher in mice lacking
bArr1. To further determine the biochemical mechanisms, we
used splenocytes and peritoneal cells from naive mice, and
stimulated them with LPS and polymicrobial culture. Inter-
estingly, LPS-induced IL-6 and TNFa levels from the KO
splenic cells were signiﬁcantly higher compared to the WT
cells (Figure 7A). This response was quite the opposite in the
peritoneal cells from the KO mice with respect to IL-6 pro-
duction (Figure 7B). There was no difference, however, in2305
Table 3 Immune Suppression in Response to Sepsis
Organs WT b-Arr1/ b-Arr1þ/
Splenocytes
IL-6 9.7  3.3 6.5  2.6 51.9  42.6
TNFa 36.8  19.2 15.2  7.6 45.9  30.1
IFN-g 4.6  2.2 1.1  0.2 8.9  2.3
Peritoneal cells
IL-6 7.6  5.1 10.7  4.8 3.8  0.9
TNFa 5.3  2.1 25.2  12.3 3.6  0.7
IFN-g 37.2  27.3 36.3  29.5 5.2  2.2
Cytokine production by splenocytes and peritoneal cells following ex vivo
lipopolysaccharide stimulation shown as fold change over unstimulated
cells for each mouse. nZ 6 to 8 mice for each genotype with data pooled
from two independent experiments.
WT, wild type.
Figure 7 Role of b-arrestin-1 in cytokine production in in vitro cell
culture models. Spleen and resident peritoneal cells from the three geno-
types were collected and processed. Equivalent number of cells were plated
and treated with lipopolysaccharide (LPS) and polymicrobial culture at
Sharma et alcytokine production following polymicrobial stimulation of
either population. This suggests that bArr1 plays a cell- and
stimuli-speciﬁc role in mediating cytokine production in vitro.
Given the range of receptors and signalosomes used in poly-
microbial sepsis42 and the potential for bArr1 to intercept and
regulate downstream effects,9,10,43 we ﬁrst wanted to test
whether the hyperinﬂammatory phenotype observed in septic
KO mice stems from bArr1’s role in the immune cells. To
assess this, we generated bone marrow chimeras of WT and
bArr1 KO mice with donor and recipient genotypes
comprising the hematopoietic or the nonhematopoietic com-
partments, respectively. The chimericmice were found to have
>92% donor-derived leukocytes in the blood, using ﬂow
cytometry to distinguish between 45.1 and 45.2 alleles, except
in the case of KO>KO transfers. The four groups of chimeric
mice were subjected to CLP and cytokine production, immune
cell inﬁltration (to the site of infection), and then bacterial
clearance was determined. Contrary to our expectations, we
found that 12 hours after CLP, the nonhematopoietic bArr1
KO mice had signiﬁcantly elevated levels of IL-6, IL-10,
TNFa, and monocyte chemoattractant protein-1 (MCP-1) in
plasma, peritoneal ﬂuid, and spleen compared to theWT septic
group (Figure 8, AeC). Importantly, levels of these cytokines
were similar between the hematopoietic bArr1KO and theWT
septic mice, demonstrating that immune cell-speciﬁc bArr1 is
not the likely the regulator of sepsis-induced inﬂammation.
Consistent with these systemic effects, lung and liver IL-6
levels were signiﬁcantly elevated in nonhematopoietic bArr1
KO mice compared to the other groups (Figure 8D). Neither
neutrophil inﬁltration to the initial site of infection (Figure 8E)
nor systemic bacterial load (Figure 8F) was affected by the loss
of bArr1 in either cellular compartment. Together, these data
demonstrate that the nonhematopoietic bArr1 exerts a negative
regulatory role in sepsis-induced inﬂammation in mice.different concentrations and multiplicity of infection (MOI), respectively,
for 18 hours. Supernatants were then assayed for IL-6 and TNFa concen-
trations using ELISA. A and B: Data from splenocytes (A) and peritoneal
cells (B). White bars indicate wild-type; black bars, b-Arr1/. n Z 4 to 5
mice for each genotype. Error bars denote SEM. *P < 0.05, **P < 0.01, and
***P < 0.001 compared to WT as determined by 2-way analysis of variance
followed by Bonferroni post test. WT, wild type.Discussion
Sepsis is a highly integrative pathophysiological disorder
that if left untreated can result in multiple organ damage and2306mortality. In animal models of sepsis, host inﬂammatory
sequelae, including humoral response, cellular inﬁltration,
lymphoid apoptosis, and consequent immune suppression,
have been identiﬁed as important factors in determining host
susceptibility. The data presented here demonstrate a critical
role for bArr1 speciﬁcally in sepsis-induced inﬂammation
and mortality, while ruling out the likely role for bArr1 in
chemotaxis (to the site of infection), bacterial killing, thymic
apoptosis, and immune suppression. Interestingly, the role
of bArr1 in polymicrobial sepsis-induced mortality is
strikingly opposite to our previous ﬁndings on bArr1 in the
endotoxemia model of sepsis. It must be noted, however,
that in both models, inﬂammation correlated and could be
predictive of susceptibility to disease progression. This
difference in outcome in endotoxemia and polymicrobial
sepsis has also been observed for b-Arrestin-2 (bArr2)12,44
and IFN alpha-beta receptor (IFNAR) KO mice, which
were similarly protected from the former, but susceptible to
the latter, model of sepsis.45 This highlights the difference in
pathophysiology of endotoxemia and polymicrobial sepsis,
with the instigating stimuli being endotoxin in the former
versus gut microbes and necrotizing tissue in the latter.
bArr1 is also a potential modulator of other inﬂammatory
diseases, including colitis,14 arthritis,46 and experimental
autoimmune encephalomyelitis,16 although its loss is, sur-
prisingly, protective in these models. This suggests that the
stimulus and ensuing inﬂammatory sequelae dictate the role
bArr1 plays in modulating the disease, and therefore, un-
derstanding its mode of action in these different diseases in
the context of instigating stimuli is important. Similar to theajp.amjpathol.org - The American Journal of Pathology
Figure 8 Nonhematopoietic b-arrestin-1 in sepsis-induced inﬂammation. Bone marrow chimeras were generated. The four groups of mice were subjected
to cecal ligation and puncture (CLP) with a 16-guage needle and 12 hours later euthanized for sample collection. AeD: Cytokine levels as determined by ELISA
in plasma (A), peritoneal ﬂuid (B), spleen (C), and lung and liver lysates (D). E and F: Peritoneal neutrophil inﬁltration (E) and blood bacterial load (F) in
septic mice are shown as total count and CFU/mL, respectively. Data in AeD are presented relative to wild type (WT) for each group. The chimeric
nomenclature used is donor>recipient such that the chimeric mouse has the donor’s hematopoietic cells and recipient’s nonhematopoietic cells. Data are
pooled from at least two independent experiments, except for the KO>KO group. nZ 8 to 21, WT>WT, WT>KO, and KO>WT; nZ 5, KO>KO. Error bars denote
SEM. *P < 0.05, **P < 0.01, and ***P < 0.001 using Student’s t-test. CFU, colony-forming units; KO, knockout.
b-Arrestin-1 Inhibits Inﬂammationrole of bArr1, bArr2 (also known as arrestin-3) has also been
shown to negatively regulate polymicrobial sepsis, both in
surgical CLP as well as a nonsurgical sepsis model.20,44
Whether bArr1 and bArr2 regulate similar or distinct path-
ways in polymicrobial sepsis will be pursued in future studies.
In various disease models and in vitro studies, bArr1 has
been ascribed diverse regulatory roles affecting immune
cells. We therefore examined the differences in response to
polymicrobial and LPS stimulation, using splenocytes and
basal peritoneal cells as in vitro models. Curiously, the role
of bArr1 in cytokine production (speciﬁcally, IL-6) in
response to LPS was found to be different based on the
cellular model used, similar to what we had observed earlier
with respect to IFN-g production from CD11b and
CD11bþ splenocytes.12 Because of this perplexity, we
further tested whether bArr1 in immune cells is responsible
for the observed results in sepsis, and surprisingly, uncov-
ered the dominant-negative regulatory role for bArr1 in the
nonhematopoietic cells in sepsis-induced inﬂammation.
Although the identity of these cells remains the subject ofThe American Journal of Pathology - ajp.amjpathol.orgfuture research, our results demonstrate that the role of
bArr1 is highly context dependent and therefore highlights
major drawbacks in concluding the role of b-arrestins in
inﬂammation based solely on in vitro cell culture studies.
Given the importance of nonimmune cells such as
endothelial and neuronal cells in sepsis progression, the role
of the nonhematopoietic compartment in sepsis-induced
inﬂammation in general is not surprising. However, because
in previous studies the role of bArr1 in modulating
inﬂammation has been extensively studied in, and attributed
to, cells of hematopoietic origin (immune cells),9,12,16,43 our
results on the role of nonhematopoietic bArr1 in septic
inﬂammation is unexpected and deserves further attention. It
should be noted that bArr1 was originally discovered for its
role in desensitization of GPCRs3 and more recently has
been implicated in biased signaling from GPCRs.47 Many
GPCRs, including C5aR,48,49 adenosine receptors,50,51 and
adrenergic receptors,52 have all been shown to play a critical
role in sepsis pathogenesis. Interestingly, similar to our re-
sults, adenosine receptor (A2B) in the nonhematopoietic2307
Sharma et alcells was also found to have a critical role in negatively
regulating inﬂammation in response to sepsis.51 Whether
bArr1 is involved in regulating these or other GPCRs in the
nonhematopoietic cells in the context of sepsis progression
will be examined in future studies.
Taken together in this study, our data provide evidence
that bArr1 is a negative regulator of sepsis-induced
inﬂammation and mortality. Even though previous studies
have focused on the role of immune cell-speciﬁc bArr1 in
inﬂammation, our results demonstrate that bArr1 in the
nonhematopoietic cells functions as a negative regulator of
sepsis-induced inﬂammation. Future studies will focus on
identifying the appropriate physiological model to under-
stand the biochemical basis by which bArr1 suppresses
sepsis-mediated inﬂammation. These studies will likely
open up new avenues for development of therapeutic stra-
tegies against this devastating disorder.Acknowledgments
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